Interaction between nutrition and inflammation in end-stage renal disease

Blood Purification

Volumn 18, Issue 4, 2000, Pages 333-336

  Bistrian, Bruce R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; FISH OIL; GROWTH HORMONE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NANDROLONE; PENTOXIFYLLINE; THALIDOMIDE;

ACUTE PHASE RESPONSE; CONFERENCE PAPER; CYTOKINE PRODUCTION; DIET THERAPY; HEMODIALYSIS; HYPOALBUMINEMIA; INFLAMMATION; KIDNEY FAILURE; MALNUTRITION; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 0033802930     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014458     Document Type: Conference Paper

References (58)

1. Levine B, Kalman J, Mayer L, Fillitit M. Packer M: Elevated levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-241.
2. McMurray J, Abdullah I, Dargie H, Shapiro D: Increased concentrations of tumor necrosis factor in 'cachectic' patients with severe chronic heart failure. Br Heart J 1991;66:356-358.
3. De Godoy I, Donahue M, Calhoun W, Mancino J, Rogers R: Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. Am J Resp Crit Care Med 1996;153:633-637.
4. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, Huber C: Serum level of cytokines in chronic liver diseases. Gastroenterology 1992;103:264-274.
5. Elsasser-Beile V, von Kleist S, Gerlach S, Gallati H. Monting J: Cytokine production in whole blood cultures of patients with Crohn's disease and ulcerativc colitis. J Clin Lab Anal 1994;8:447-451.
6. Falconer J, Fearon K, Plester C, Ross J, Carter D: Cytokines, the acute phase response and resting energy expenditure in cachetic patients with pancreatic cancer. Ann Surg 1994;219: 325-331.
7. Cederholm T, Wretlind B, Hellstron K: Enhanced generation of interleukin 1 beta and interleukin 6 may contribute to the cachexia of chronic disease. Am J Clin Nutr 1997;65:876-882.
8. Pereira B, Shapiro L, King A, Falagas M, Strom J, Dinarello C: Plasma levels of IL-1 beta, TNF-alpha, and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 1994;45:850-896.
9. Oettinger CW, Bland LA, Oliver JC, Ardvino M, McAllister S, Favero M: The effect of uremia on tumor necrosis factor-alpha release after in vitro whole blood endotoxin challenge. J Am Soc Nephrol 1994;4:1890-1895.
10. Higuchi T, Yamamoto C, Kuno T, Mizano M, Takahashi S, Kammatsase K: Increased production of interleukin beta and interleukin-1 receptor antagonist by peripheral blood mononuclear cells in undialyzed chronic renal failure. Nephron 1997;76:26-31.
11. Ryan JJ, Beynon H, Rees A, Cassidy M: In vitro production of tumor necrosis factor by monocytes cultured from dialysis patients. Kidney Int 1993;41(suppl):226-229.
12. McKenna R, McDonald C, Bernstein K, Ruch D: Increased production of tumor necrosis factor alpha activity by hemodialysis but not peritoneal dialysis patients. Nephron 1994;67: 190-196.
13. Brauner A, Hylander B. Wretlind B: Tumor neurosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996;27:402-408.
14. Lin Y, Chang D, Shaio M, Lu K, Chyr S, Sheih S: Cytokine production during hemodialysis, effects of dialytic membrane and complement activation. Am J Nephrol 1996;16:293-299.
15. Abdullah M, Wild G, Jacob V, Milford-Ward A, Ryan R, Zanaty M, Ali H. el Nahas A: Cytokines and the malnutrition of chronic renal failure. Miner Electrolyte Metab 1997;23:237-242.
16. Kaizu Y, Kimura M, Yoneyama T, Miyaji K, Hibi I, Kumagir H: Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis 1998;31:93-100.
17. Dinarello C: Interleukin-1 and the pathogencsis of the acute phase response. N Engl J Med 1984;311:1413-1418.
18. Beutler B, Cerami A: The biology of cachectin/ TNF - a primary mediator of the host response. Ann Rev Immunol 1989;7:625-655.
19. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-454.
20. Moshage H: Cytokines and the hepatic acute phase response. J Pathol 1997;191:257-266.
21. Jurado R: Iron, infections, and anemia of inflammation. Clin Infect Dis 1997;25:888-895.
22. Ling P, Istfan N, Colon E, Bistrian B: Differential effects of interleukin-1 receptor antagonist in cytokine-and endotoxin-treated rats. Am J Physiol 1995;268:255-261.
23. Jiang Q, Detolla L, Singh I, Gatdula L, Fitzgerald B, Van Rooijen N, Cross A, Hasday J: Exposure to febrile temperature upregulates expression of pyrogenic cytokines in endotoxin-challenged mice. Am J Physiol 1999;276:1653-1680.
24. Rothschild M, Oratz M, Schreiber S: Albumin synthesis: N Engl J Med 1993;329:1001-1006.
25. Yap S, Hafkenscheid J: Effect of starvation on the synthesis rate of albumin in vivo and its relationship to the concentrations of amino acids in the peripheral blood, the portal circulation and in the liver cytosolic fraction. Ann Nutr Metab 1981;75:158-184.
26. Lunn P, Austin S: Dietary manipulation of plasma albumin concentration. J Nutr 1983; 113:1791-1802.
27. Doweiko J, Nompleggi D: The role of albumin in human physiology and pathophysiology. III. Albumin and disease states. J Parenter Enteral Nutr 1991;15:476-483.
28. Bistrian B, Sherman M, Blackburn G, Marshall R, Shaw C: Cellular immunity in adult marasmus. Arch Intern Med 1977;137:1408-1411.
29. Mitch W, Walser M, Steinman T, Hill S, Zeger S, Tungsanga K: The effect of a keto acid-amino acid supplement to a restricted diet on the progression of chronic renal failure. N Engl J Med 1984;311:623-629.
30. Ling P, Schwartz J, Jeevanandam M, Gauldie J, Bistrian B: Metabolic changes in rats during a continuous infusion of recombinant interleukin I. Am J Physiol 1998;220:305-312.
31. Ling P, Schwartz J, Bistrian B: Mechanisms of host wasting induced by administration of cytokines in rats. Am J Physiol 1997;272:333-339.
32. Smith B, Conn C, Kluger M: Experimental cachexia: Effects of MCA sarcoma in the Fischer rat. Am J Physiol 1993;205:376-384.
33. Flores E, Bistrian B, Pomposelli J, Dinarello C, Blackburn G, Istfan N: Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. J Clin Invest 1989;83:1614-1622.
34. Haubitz M, Brunkhorst R, Wrenger E, Froese P, Schulze M, Koch K: Chronic induction of C-reactive protein by hemodialysis but not peritoneal dialysis therapy. Periton Dial Int 1996;16:158-162.
35. McIntyre C, Harper I, MacDougal I, Raine A, Williams A, Baker L: Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients. Clin Nephrol 1997;48: 371-374.
36. Han D, Lee S, Kang S, Choi K, Lee H, Choi K, Lee J: Factors affecting low values of serum albumin in CAPD patients. Adv Periton Dial 1996;12:288-292.
37. Kaysen G, Stevenson F, Depner T: Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 1997;29:658-688.
38. Lowrie E: Acute-phase inflammatory process contributes to malnutrition, anemia, and possible other abnormalities in dialysis patients: Am J Kidney Dis 1998;32(suppl 4):105-112.
39. Ikizler T, Wingard R, Harvell J, Shyr Y, Hakin R: Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study. Kidney Int 1999;55:1945-1981.
40. Barany P, Divino Filho J, Bergstrom J: High C-reactive protein is a strong predictor of resistance to erythropoietin in dialysis patients. Am J Kidney Dis 1997;29:565-568.
41. Owen W, Lew N, Liu Y, Lowrie E, Lazurus J: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993;329:1001-1006.
42. Kaysen G, Yeun J, Depner T: Albumin synthesis catabolism and distribution in dialysis patients. Miner Electrolyte Metab 1997;23:218-224.
43. Qureski A, Alvestrand A, Danielson A. Divino-Filho J, Gutierrez A, Lindholm Berstrom J: Factors predicting malnutrition in hemodialysis patients: A cross-sectional study. Kidney Int 1998;53:773-782.
44. Yuen J, Kaysen G: Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients. Am J Kidney Dis 1997;30: 923-997.
45. Kaysen G, Rathore V, Shearer G, Depner T: Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int 1995;48:510-516.
46. Fearon K, Falconer J, Slater L, McMillan D, Raes J, Preston T: Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an on-going acute-phase protein response. Ann Surg 1998;777:249-254.
47. Leiter L, Marliss E: Survival during fasting may depend on fat as well as protein stores. J Am Med Assoc 1982;248:2308-2307.
48. Kopple J; McCollum Award Lecture, 1996: Protein-energy malnutrition in maintenance dialysis patients. Am J Clin Nutr 1997;65: 1544-1557.
49. Ikizler T, Wingard R, Hakim R: Interventions to treat malnutrition in dialysis patients: The role of dose of dialysis, intradialytic parenteral nutrition, and growth hormone. Am J Kidney Dis 1995;26:256-265.
50. Kenler A, Swails W, Driscoll D, DcMichele S, Daley B, Babineau T, Peterson M, Bistrian B: Early enteral feeding in post surgical cancer patients, fish oil structured lipid-based formula versus a standard polymeric formula. Ann Surg 1998;223:316-333.
51. Ziegler T, Gatzen C, Wilmore D: Strategy for attenuating protein-catabolic responses in the critically ill. Ann Rev Med 1994;45:459-480.
52. Cooney R, Owens E, Jurasinski C, Gray K, Vannice J, Vary T: Interleukin-1 receptor antagonist prevents sepsis-induced inhibition of protein synthesis. Am J Physiol 1994;267:636-641.
53. Yeh S, Schuster M: Geriatric cachexia: The role of cytokines. Am J Clin Nutr 1999;70:183-187.
54. Dahn M, Lange P, Jacobs L: Insulin-like growth factor-1 production is inhibited in human sepsis. Arch Surg 1988;123:1409-1414.
55. Fougue D, Peng S, Kopple J: Impaired metabolic response to recombinant insulin-like growth factor in dialysis patients. Kidney Int 1995;74:876-883.
56. Calkins J, Sigel M, Nankin H, Lin T: Interleukin-1 inhibits lipid cell steroidogencsis in primay culture. Endocrinology 1988;123:1605-1610.
57. Iglesias P, Diez J, Fernandez-Reyes M, Aguilera A, Burgues S, Martinez-Ara J, Miguel J, Gomez-Pan A. Selgas R: Recombinant human growth hormone therapy in malnourished dialysis patients: A randomized controlled study. Am J Kidney Dis 1998;32:454-463.
58. Johansen K, Mulligan K, Schambelan M: Anabolic effects of nandrolone decanoate in patients receiving dialysis. J Am Med Assoc 1999; 281:1275-1281.